Showing results (1-10 of 27) with videos related to
Sort By:
Pageof 3
Current Opinion in Hematology|February 28, 2008
Novel strategies for relapsed and refractory acute myeloid leukemiaAnthony R Mato, Alicia Morgans, Selina M LugerUrologic Oncology|May 15, 2018
Decision analysis defining optimal management of clinical stage 1 high-risk nonseminomatous germ cell testicular cancer with lymphovascular invasionSvetlana Avulova, Clayton Allen, Alicia Morgans, et al.The Journal of Clinical Investigation|February 3, 2004
Defects in secretion, aggregation, and thrombus formation in platelets from mice lacking Akt2Donna Woulfe, Hong Jiang, Alicia Morgans, et al.Frontiers in Oncology|October 2, 2019
Past, Current, and Future of Immunotherapies for Prostate CancerAdeline N Boettcher, Ahmed Usman, Alicia Morgans, et al.Southern Medical Journal|May 3, 2024
Androgen Deprivation Therapy/Androgen Receptor Signaling Inhibitor Treatments for Prostate Cancer: Pathophysiology and Review of Effects on Cardiovascular DiseaseRichard Orji, Alicia Morgans, Eiman Jahangir, et al.Obstetrical & Gynecological Survey|February 20, 2016
Procedures and Uterine-Sparing Surgeries for Managing Postpartum Hemorrhage: A Systematic ReviewNila A Sathe, Frances E Likis, Jessica L Young, et al.BJUI Compass|October 21, 2022
Functional impact of androgen-targeted therapy on patients with castration-resistant prostate cancerTomasz M Beer, Neal Shore, Alicia Morgans, et al.Clinical Breast Cancer|August 25, 2023
Survivorship Navigation for Young Women With Early-Stage Breast CancerLauren P Knelson, Shoshana Rosenberg, Craig Snow, et al.Advances in Radiation Oncology|July 21, 2021
Trimodality Treatment for Muscle-Invasive Bladder Cancer: An Institutional ExperiencePraneet Polineni, Laura Ashack, John Kalapurakal, et al.Clinical Genitourinary Cancer|October 9, 2022
A Phase II Study of sEphB4-HSA in Metastatic Castration-Resistant Prostate CancerDavid J VanderWeele, Masha Kocherginsky, Sabah Munir, et al.Pageof 3